CLINICAL_TRIALS
trial_result
· 2023-03-13
Clinical Trial Update: Plerixafor for Poorly Mobilized Lymphoma [Phase 4]
Summary
A Phase 4 clinical trial update for plerixafor in poorly mobilized lymphoma patients is noted, with status currently unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking University | Conditions: Lymphoma | Phase 4 | Status: UNKNOWN